Patent · US Active

Peptides

US11873348B2 · kind B2 · utility

1Cited by

3References

7Claims

0Family size

Assignee

ALLIGATOR BIOSCIENCE AB · SE

Inventors

Peter Ellmark · Lund, SE
Karin Hagerbrand · Hjärup, SE
Laura Varas · Lund, SE
Mattias Levin · Lund, SE
Anna Sall · Lund, SE
Laura Von Schantz · Lund, SE

Key dates

Filing date	Nov 4, 2022
Grant date	Jan 16, 2024
Priority date	—
Expiry date	Nov 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to novel bispecific polypeptides, such as antibodies, and their use in the treatment of cancers, particularly cancers expressing carcinoembryonic antigen (CEA).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.